NIAID’s Fauci on Tuberculosis: “We have much catching up to do”

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, delivered a forceful message on the need for a “storm” of attention and resources devoted to developing new TB treatment and prevention efforts.
“It is imperative that we transform the way we diagnose, treat, prevent, and control TB — through biomedical research and public [...]

Read Full Post »

A Timely Reminder of Fauci’s Call for a Transformative TB Research Agenda

What will come of Anthony Fauci’s call for a “transformative” research agenda for tuberculosis, in which doctors and scientists get new resources and support in the search for better drugs and diagnostics to combat this ancient scourge?
Fauci, head of the National Institute of Allergy and Infectious Diseases, delivered that appeal for a more aggressive approach to [...]

Read Full Post »

TB, A Global Threat That Requires New Vision, Strong Leadership

During a live interactive webcast today hosted by the Kaiser Family Foundation, an expert panel agreed that tuberculosis poses a grave global health threat and demands an innovative, multifaceted response—from new drugs to scaled-up treatment to better infection control.
The lively forum, available here, highlighted the need for an aggressive approach to the global tuberculosis epidemic [...]

Read Full Post »

Live Webcast on Global TB Featuring Renowned South African Physician/Scientist

The Kaiser Family Foundation will hold a live, interactive webcast on Tuesday, Sept. 28, at 1 p.m. EDT on the threat of tuberculosis and the U.S. strategy for combating this ancient deadly disease.
An expert panel is set to discuss this growing global health threat, including two of the U.S. government’s top infectious disease specialists and [...]

Read Full Post »

Calls for strengthened lab capacity, service delivery and better policy–while resource question looms large

Editor’s Note: This is another dispatch from the Pacific Health Summit, filed by Christine Lubinski, director of the Center for Global Health Policy.
Following NIAID Director Anthony Fauci’s powerful call for a transformative research agenda for tuberculosis, other presenters highlighted the challenges in wooing pharmaceutical companies, biotech firms and young researchers to the field of TB, [...]

Read Full Post »

Fauci: New TB research agenda desperately needed

This live blog is from the Pacific Health Summit in Seattle, a three-day meeting that opened Tuesday night. Its focus is the global response to multidrug-resistant tuberculosis.
Anthony Fauci, the longtime director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, told the Pacific Health Summit today that it was [...]

Read Full Post »

Earlier ART=Better Chance for Survival

In a significant development, the National Institute of Allergy and Infectious Diseases announced that it a trial in Haiti–investigating the impact of earlier ART therapy in HIV-positive patients—would be ended early because the results were overwhelming; the findings showed that HIV-infected adults are more likely to survive if they start antiretroviral drugs before their immune [...]

Read Full Post »

More Stimulus Funding News

As we recently mentioned on this blog, the economic stimulus package included a decent chunk of money for new scientific research.
 
Here’s a bevy of links for interested scientists:
 
This first one is a broad overview of NIAID’s role in doling out some of the Economic Recovery Act money: http://www.niaid.nih.gov/ncn/recovery/
Now some more detailed funding opportunites:

RFA-RR-09-007, Recovery [...]

Read Full Post »